Valuation: Shenzhen YHLO Biotech Co., Ltd.

Capitalization 7.57B 1.11B 946M 866M 818M 1.52B 105B 1.54B 10.26B 4B 50.37B 4.18B 4.09B 174B P/E ratio 2026 *
21.6x
P/E ratio 2027 * 20.2x
Enterprise value 7.57B 1.11B 946M 866M 818M 1.52B 105B 1.54B 10.26B 4B 50.37B 4.18B 4.09B 174B EV / Sales 2026 *
3.11x
EV / Sales 2027 * 2.96x
Free-Float
45.98%
Yield 2026 *
2.26%
Yield 2027 * -
1 day-2.13%
1 week-3.48%
Current month-3.48%
1 month-9.44%
3 months-7.75%
6 months-11.13%
Current year-6.13%
1 week 13.28
Extreme 13.28
13.89
1 month 13.28
Extreme 13.28
15.18
Current year 13.28
Extreme 13.28
17
1 year 13.28
Extreme 13.28
17
3 years 13.28
Extreme 13.28
28.27
5 years 13.28
Extreme 13.28
52.71
10 years 13.28
Extreme 13.28
52.71
Manager TitleAgeSince
Chief Executive Officer 42 30/11/2012
Director of Finance/CFO 47 21/12/2022
Chief Tech/Sci/R&D Officer 44 30/09/2015
Director TitleAgeSince
Chairman 35 31/12/2017
Chairman 42 30/11/2012
Director/Board Member 51 27/06/2019
Change 5d. change 1-year change 3-years change Capi.($)
-2.13%-3.48%-8.82%-22.95% 1.12B
-0.36%-0.58%+12.02%+4.10% 12.77B
-0.05%-0.04%+16.16%-4.95% 9.35B
-0.21%+1.85%+50.62%+31.35% 5.62B
+1.20%+3.50%+1.78%-24.68% 5.52B
+0.09%-1.37%-17.41%+36.86% 4.85B
+0.37%+1.54%-14.96%-9.64% 4.36B
-0.94%-4.09% - - 3.29B
+3.77%+3.55%-1.32%-75.19% 1.95B
+3.16%+5.56%+9.74%-44.81% 1.72B
Average +0.49%+2.59%+5.31%-12.21% 5.05B
Weighted average by Cap. +0.20%+0.91%+9.59%-1.41%

Financials

2026 *2027 *
Net sales 2.44B 358M 304M 279M 263M 488M 33.75B 494M 3.3B 1.29B 16.2B 1.34B 1.32B 56.02B 2.55B 376M 319M 292M 276M 512M 35.4B 518M 3.46B 1.35B 16.99B 1.41B 1.38B 58.76B
Net income 381M 55.98M 47.56M 43.55M 41.12M 76.35M 5.28B 77.24M 516M 201M 2.53B 210M 206M 8.76B 374M 54.92M 46.66M 42.72M 40.34M 74.9M 5.18B 75.77M 506M 197M 2.48B 206M 202M 8.59B
Net Debt - -
Logo Shenzhen YHLO Biotech Co., Ltd.
Shenzhen YHLO Biotech Co Ltd is a China-based company primarily engaged in the provision of in vitro diagnostic instruments. The Company mainly focuses on the research, development, production, and sales of in vitro diagnostic instruments and related reagents based on chemiluminescence immunoassay, as well as the agency sales of some non-self-produced medical device products. The Company's products are used in fields such as autoimmunity, reproductive health, diabetes, and infectious diseases. The Company's products are sold in domestic and international markets.
Employees
1,678
Date Price Change Volume
08/05/26 13.25 ¥ -0.60% 7,295,288
07/05/26 13.33 ¥ -2.13% 7,456,377
06/05/26 13.62 ¥ -1.38% 5,871,020
30/04/26 13.81 ¥ -3.63% 6,275,844
29/04/26 14.33 ¥ +2.43% 5,246,592
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
13.33CNY
Average target price
17.65CNY
Spread / Average Target
+32.38%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688575 Stock